Outcome of patients with compensated liver cirrhosis with hepatitis B virus + hepatitis C virus coinfection treated with paritaprevir/ombitasvir/ritonavir, dasabuvir with ribavirin: a national cohort study
| Autor: | L. Tugui, Carmen Monica Preda, Ileana Constantinescu, Mircea Diculescu, Carmen Popescu, Emanoil Ceausu, Radu Voiosu, M. Manuc, A Oproiu |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Hepatitis B virus
Dasabuvir Hepatology business.industry Hepatitis C virus Ribavirin medicine.disease_cause medicine.disease Virology Ombitasvir 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine chemistry Paritaprevir 030220 oncology & carcinogenesis medicine Coinfection 030211 gastroenterology & hepatology Ritonavir business medicine.drug |
| Zdroj: | Journal of Hepatology. 66:S295-S296 |
| ISSN: | 0168-8278 |
| DOI: | 10.1016/s0168-8278(17)30907-8 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect